Learn more about our policy experts.

Media Contacts

Angela Bradbery, Director of Communications
w. (202) 588-7741
c. (202) 503-6768
abradbery@citizen.org, Twitter

Barbara Holzer, Broadcast Manager
w. (202) 588-7716
bholzer@citizen.org

Karilyn Gower, Press Officer
w. (202) 588-7779
kgower@citizen.org

Ben Somberg, Press Officer (regulatory matters)
w. (202) 588-7742
bsomberg@citizen.org, Twitter

Other Important Links

Press Release Database
Citizen Vox blog
Texas Vox blog
Consumer Law and Policy blog
Energy Vox blog
Eyes on Trade blog
Facebook/publiccitizen

Follow us on Twitter

 

March 18, 2013

Winners of ACTA and SOPA Battles Call for Exclusion of ‘Intellectual Property’ From EU-U.S. Trade Talks

Current Talks Favor Corporations, Exclude Public Interest

WASHINGTON, D.C. – Planned trade negotiations between the United States and the European Union should exclude any provisions related to patents, copyright, trademarks, data protection, geographical indications or other forms of so-called “intellectual property” (IP), a transatlantic coalition of 45 consumer, public health and Internet freedom groups said today in a civil society declaration.

The groups, many of which helped organize mass demonstrations and online protests last year that led to the collapse of the Anti-Counterfeiting Trade Agreement in Europe and the Stop Online Piracy Act in the U.S., warned that such provisions could limit free speech, constrain access to educational materials such as textbooks and academic journals, and, in the case of medicines, raise health care costs and contribute to preventable suffering and death.

In his State of the Union address, President Barack Obama announced plans to negotiate a transatlantic free trade agreement (TAFTA), also referred to as the Transatlantic Trade and Investment Partnership.

“Past trade agreements negotiated by the U.S. and EU have significantly increased the privileges of multinational corporations to exclude competitors, expand monopoly power and control the rules of the information economy,” said Peter Maybarduk, Global Access to Medicines program director at Public Citizen.

Important rules governing technology, health and culture should be debated in the U.S. Congress, the European Parliament, national parliaments and other transparent forums where all stakeholders can be heard, not in closed negotiations that give privileged access to corporate insiders, the groups said. Unless intellectual property is excluded from these talks, the outcome will be an agreement that inflicts the worst of both regimes’ rules, they said.

The U.S. also is negotiating a Trans-Pacific Partnership (TPP) free trade agreement intended to eventually incorporate most members of the Asia-Pacific Economic Cooperation forum. Taken together, the TPP and TAFTA could represent an effort to lock out the BRICS countries – Brazil, Russia, India, China and South Africa – from global rulemaking on technology and information economics. The BRICS countries have challenged U.S. and EU efforts to expand patent-based pharmaceutical monopolies and copyright controls at international forums.

“TAFTA will be a game changer in the IP debate because American and European politicians are keen on shaping globalization and setting IP rules for the 21st century outside the official global forums, said Burcu Kilic, legal counsel for the Global Access to Medicines Program at Public Citizen. “BRICS are seeking development while EU and U.S. industries are pushing a conflicting agenda.”

The groups warned policymakers on both sides of the Atlantic that any attempt to augment patent or copyright rules in favor of right holders and against consumer interests would be a major mistake and would encounter strong public resistance.

To read the declaration, visit http://www.citizen.org/ip-out-of-tafta.

###

Copyright © 2014 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.

 

To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.